Selective Cytopheretic Device (QUELimmune): A Leukocyte Processing, Immunomodulatory Device.
作者信息
Pino Christopher J, Johnston Kimberly A, Westover Angela J, Humes H David
机构信息
Innovative BioTherapies, Ann Arbor, Michigan; and Department of Internal Medicine/Nephrology, University of Michigan, Ann Arbor, Michigan.
出版信息
J Am Soc Nephrol. 2025 Jan 1;36(1):144-146. doi: 10.1681/ASN.0000000569. Epub 2024 Nov 5.
Abstract
摘要
相似文献
1
Selective Cytopheretic Device (QUELimmune): A Leukocyte Processing, Immunomodulatory Device.选择性血细胞去除装置（QUELimmune）：一种白细胞处理、免疫调节装置。
J Am Soc Nephrol. 2025 Jan 1;36(1):144-146. doi: 10.1681/ASN.0000000569. Epub 2024 Nov 5.
2
The Impact of the Selective Cytopheretic Device on Neutrophil-to-Lymphocyte Ratios and Hematological Parameters in Acute Kidney Injury: A Pooled Analysis.选择性血细胞分离装置对急性肾损伤患者中性粒细胞与淋巴细胞比值及血液学参数的影响：一项汇总分析
Nephron. 2025 May 30:1-13. doi: 10.1159/000546528.
3
Selective Cytopheretic Device Use in Continuous Kidney Replacement Therapy in Children: A Cohort Study With a Historical Comparator.儿童连续性肾脏替代治疗中选择性细胞分离装置的应用：一项采用历史对照的队列研究
Kidney Med. 2024 Feb 15;6(4):100792. doi: 10.1016/j.xkme.2024.100792. eCollection 2024 Apr.
4
Current Experience Using the Selective Cytopheretic Device for Continuous Immunomodulation in Acute Kidney Injury and Multiorgan Failure.
Blood Purif. 2025 May 3. doi: 10.1159/000546219.
5
Immunomodulatory effects of a cell processing device to ameliorate dysregulated hyperinflammatory disease states.细胞处理设备对改善失调性过度炎症疾病状态的免疫调节作用。
Sci Rep. 2024 Jun 3;14(1):12747. doi: 10.1038/s41598-024-63121-9.
6
Use of the Selective Cytopheretic Device in Critically Ill Children.选择性血细胞去除装置在危重症儿童中的应用。
Kidney Int Rep. 2020 Dec 19;6(3):775-784. doi: 10.1016/j.ekir.2020.12.010. eCollection 2021 Mar.
7
Rationale and Design of NEUTRALIZE-AKI: A Multicenter, Randomized, Controlled, Pivotal Study to Assess the Safety and Efficacy of a Selective Cytopheretic Device in Patients with Acute Kidney Injury Requiring Continuous Kidney Replacement Therapy.NEUTRALIZE-AKI：一项多中心、随机、对照、关键性研究的原理和设计，旨在评估一种选择性细胞因子吸附装置在需要连续肾脏替代治疗的急性肾损伤患者中的安全性和疗效。
Nephron. 2024;148(1):43-53. doi: 10.1159/000531880. Epub 2023 Jul 13.
8
Selective cytopheretic inhibitory device with regional citrate anticoagulation and portable sorbent dialysis.具有局部枸橼酸盐抗凝和便携式吸附透析的选择性细胞滤过抑制装置。
Artif Organs. 2013 Feb;37(2):203-10. doi: 10.1111/j.1525-1594.2012.01541.x. Epub 2012 Oct 16.
9
A selective cytopheretic inhibitory device to treat the immunological dysregulation of acute and chronic renal failure.一种选择性细胞因子吸附抑制装置，用于治疗急性和慢性肾衰竭的免疫失调。
Blood Purif. 2010;29(2):183-90. doi: 10.1159/000245645. Epub 2010 Jan 8.
10
Extracorporeal therapies in sepsis: a comprehensive review of the Selective Cytopheretic Device, Polymyxin B and Seraph cartridges.脓毒症的体外治疗：对选择性细胞去除装置、多粘菌素B和Seraph柱的全面综述
Ren Fail. 2025 Dec;47(1):2459349. doi: 10.1080/0886022X.2025.2459349. Epub 2025 Feb 17.
引用本文的文献
1
Management dilemma in choosing evolving treatments in neutropenic septic shock.中性粒细胞减少性脓毒性休克中选择不断发展的治疗方法时的管理困境
Pediatr Nephrol. 2025 Jun 21. doi: 10.1007/s00467-025-06798-y.
2
Immune Cell Therapy: Promising Approach to Reduce Chronic Kidney Disease Risk in Heart Failure.免疫细胞疗法：降低心力衰竭患者慢性肾病风险的前景疗法。
J Am Heart Assoc. 2025 Mar 4;14(5):e039871. doi: 10.1161/JAHA.124.039871. Epub 2025 Feb 25.
本文引用的文献
1
Immunomodulatory effects of a cell processing device to ameliorate dysregulated hyperinflammatory disease states.细胞处理设备对改善失调性过度炎症疾病状态的免疫调节作用。
Sci Rep. 2024 Jun 3;14(1):12747. doi: 10.1038/s41598-024-63121-9.
2
Selective Cytopheretic Device Use in Continuous Kidney Replacement Therapy in Children: A Cohort Study With a Historical Comparator.儿童连续性肾脏替代治疗中选择性细胞分离装置的应用：一项采用历史对照的队列研究
Kidney Med. 2024 Feb 15;6(4):100792. doi: 10.1016/j.xkme.2024.100792. eCollection 2024 Apr.
3
Rationale and Design of NEUTRALIZE-AKI: A Multicenter, Randomized, Controlled, Pivotal Study to Assess the Safety and Efficacy of a Selective Cytopheretic Device in Patients with Acute Kidney Injury Requiring Continuous Kidney Replacement Therapy.NEUTRALIZE-AKI：一项多中心、随机、对照、关键性研究的原理和设计，旨在评估一种选择性细胞因子吸附装置在需要连续肾脏替代治疗的急性肾损伤患者中的安全性和疗效。
Nephron. 2024;148(1):43-53. doi: 10.1159/000531880. Epub 2023 Jul 13.
4
Use of the Selective Cytopheretic Device in Critically Ill Children.选择性血细胞去除装置在危重症儿童中的应用。
Kidney Int Rep. 2020 Dec 19;6(3):775-784. doi: 10.1016/j.ekir.2020.12.010. eCollection 2021 Mar.
5
Regenerative Medicine and Immunomodulatory Therapy: Insights From the Kidney, Heart, Brain, and Lung.再生医学与免疫调节疗法：来自肾脏、心脏、大脑和肺部的见解
Kidney Int Rep. 2018 Jan 5;3(4):771-783. doi: 10.1016/j.ekir.2017.12.012. eCollection 2018 Jul.
6
A Multi-Center, Randomized, Controlled, Pivotal Study to Assess the Safety and Efficacy of a Selective Cytopheretic Device in Patients with Acute Kidney Injury.一项多中心、随机、对照、关键研究，旨在评估选择性血细胞去除装置对急性肾损伤患者的安全性和有效性。
PLoS One. 2015 Aug 5;10(8):e0132482. doi: 10.1371/journal.pone.0132482. eCollection 2015.
7
The bioartificial kidney: current status and future promise.生物人工肾：现状与未来前景。
Pediatr Nephrol. 2014 Mar;29(3):343-51. doi: 10.1007/s00467-013-2467-y. Epub 2013 Apr 26.
8
Intensities of renal replacement therapy in acute kidney injury: a systematic review and meta-analysis.急性肾损伤中肾脏替代治疗的强度：系统评价和荟萃分析。
Clin J Am Soc Nephrol. 2010 Jun;5(6):956-63. doi: 10.2215/CJN.09111209. Epub 2010 Apr 15.
9
A selective cytopheretic inhibitory device to treat the immunological dysregulation of acute and chronic renal failure.一种选择性细胞因子吸附抑制装置，用于治疗急性和慢性肾衰竭的免疫失调。
Blood Purif. 2010;29(2):183-90. doi: 10.1159/000245645. Epub 2010 Jan 8.
10
Efficacy and safety of renal tubule cell therapy for acute renal failure.肾小管细胞疗法治疗急性肾衰竭的疗效与安全性。
J Am Soc Nephrol. 2008 May;19(5):1034-40. doi: 10.1681/ASN.2007080895. Epub 2008 Feb 13.
Zotero 插件